(주) 뷰노

VUNO Med®-BoneAge is the first in Korea to receive MFDS approval.

  • 2018. 05. 16

Ministry of Food and Drug Safety(MFDS) has approved VUNO Med®-BoneAge,

AI-based diagnostic software, as a medical device.


The MFDS evaluated product accuracy(performance) through clinical trials

and found that, on average, 0.9 months of difference compared to bone age

assessed by doctors. 


The MFDS has supported VUNO Med®-BoneAge for customized approval from March 2017